Adams Respiratory Therapeutics, Inc.
Drug developer focused on respiratory diseases reports 75% increase in sales
Published in Pharma Investments, Ventures and Law Weekly, March 5th, 2006
Commenting on the second quarter results, Michael J. Valentino noted, "I am certainly very pleased with our solid quarterly performance, mainly driven by the early strength of the cough/cold season, strong consumer demand and further market penetration of our Mucinex franchise. During the quarter, we carried a significant product backorder and it was not until mid-December when finished product made from our second guaifenesin supplier, Delta Synthetic Co., Ltd., could be shipped to customers."
Valentino added, "Despite the fact...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Abiomed, Inc.
Cardiac device maker reports 10% increase in revenue - Access Pharmaceuticals, Inc.
Drug delivery-focused company receives notice of AMEX delisting - Aceto Corp.
Chemically derived drug distributor posts decline in revenue - Advanced Life Sciences Holdings, Inc.
SBIR grant to be used for study of drug for stroke patients - Aksys, Ltd.
Dialysis systems maker responds to Nasdaq notification - Akzo Nobel
Pharmaceutical division to be separated from parent company - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
